Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
31.98
+0.03 (0.09%)
Nov 21, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3,028 | 694 | 565 | 753 | - | - |
| Market Cap Growth | 588.29% | 22.85% | -24.97% | - | - | - |
| Enterprise Value | 2,537 | 410 | 203 | 463 | - | - |
| Last Close Price | 31.95 | 10.94 | 8.94 | 15.28 | - | - |
| PB Ratio | 6.17 | 2.18 | 1.63 | 2.75 | - | - |
| P/TBV Ratio | 5.12 | 2.18 | 1.63 | 2.75 | - | - |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | - | - | - |
| Quick Ratio | 25.98 | 18.98 | 21.22 | 26.69 | 29.73 | 20.89 |
| Current Ratio | 26.35 | 19.50 | 21.53 | 26.97 | 29.86 | 21.24 |
| Return on Equity (ROE) | -31.90% | -30.10% | -21.78% | -21.34% | -22.80% | - |
| Return on Assets (ROA) | -22.36% | -20.21% | -13.73% | -12.97% | -13.80% | - |
| Return on Capital (ROIC) | -23.31% | -21.17% | -14.32% | -13.46% | -14.31% | - |
| Earnings Yield | -4.05% | -14.43% | -11.97% | -5.68% | - | - |
| FCF Yield | -3.59% | -14.07% | -10.30% | -4.54% | - | - |
| Buyback Yield / Dilution | -34.04% | -18.90% | -42.82% | -4977.96% | -95.63% | - |
| Total Shareholder Return | -34.04% | -18.90% | -42.82% | -4977.96% | -95.63% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.